2500059 (Part 1)
Study for the treatment of atopic eczema (Part 1)
18-55
- Male
- Female
April - October
7 to 14 days
9
3100
Are you
- a healthy man or woman
- between 18 and 55 years (inclusive)
- with a BMI between 18.0 and 30.0 kg/m² (inclusive)
- weighing between 45.0 and 100.0 kg (inclusive)
- who does not smoke or smokes a maximum of 10 cigarettes per week and is willing to quit smoking during the study
- and does not use daily medication
What does this trial involve?
In study 2500059 part 1, SGS CPU is investigating the treatment of atopic eczema. During +/- 14 weeks you will have the following appointments:
- a screening visit
- a stay consisting of 8 days (7 nights)
- 8 morning return visits
- an end of trial visit
Take part in this trial and
- contribute to the medicine of tomorrow
- a compensation will be provided
This study was approved by the competent Belgian health authorities and an independent ethics committee.
View information leaflet Part 1 Cohort 6 sentinel
View study dates Part 1 Cohort 6 sentinel
